| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, flaska |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| peginterferon alfa-2b 120 mikrogram, pulver till injektionsvätska, lösning, flaska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Trastuzumab 150 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Trastuzumab 150 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Pentostatin 10 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Pentostatin 10 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Ganciclovir (as ganciclovir sodium) 500 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| meropenem (som meropenemtrihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| meropenem (som meropenemtrihydrat) 500 milligram/injektionsflaska, pulver till injektionsvätska |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Hyaluronidase 1500 unit powder for solution for injection ampule |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Hyaluronidase 1500 unit powder for solution for injection ampule |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Mitomycin 2 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Mitomycin 2 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Neomycin sulfate 25 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Infliximab 100 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Infliximab 100 mg powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Imiglucerase 200 unit powder for solution for injection vial |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Imiglucerase 200 unit powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
har nämnarvärde som visar styrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Gabapentin 50 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely indometacin 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Chlorpromazine hydrochloride 5 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefuroxime (as cefuroxime axetil) 25 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Calcium glubionate 218 mg/mL and calcium lactobionate 144.6 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
2 |
| cisaprid (som cisapridmonohydrat) 1 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cisaprid (som cisapridmonohydrat) 1 milligram/milliliter, oral suspension |
har täljarvärde för koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cisaprid (som cisapridmonohydrat) 1 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cimetidine 40 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cimetidine 40 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely carbamazepine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Flucloxacillin (as flucloxacillin magnesium) 50 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefprozil 50 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefprozil 50 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefalexin 100 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cefalexin 100 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefradine 50 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Cefradine 50 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely paracetamol 24 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Chloral hydrate 28.6 mg/mL oral solution |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Chloral hydrate 28.6 mg/mL oral solution |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cefadroxil (som cefadroxilmonohydrat) 25 milligram/milliliter, oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| cefadroxil (som cefadroxilmonohydrat) 25 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely cyanocobalamin 7 microgram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Paracetamol 50 mg/mL oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| Paracetamol 50 mg/mL oral suspension |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
1 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely chloral hydrate 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |
| cefadroxil (som cefadroxilmonohydrat) 50 milligram/milliliter, oral suspension |
har nämnarvärde som visar koncentrationsstyrka |
False |
1 (qualifier value) |
Inferred relationship |
Some |
1 |